摘要
Early and accurate detection of reproductive hormone levels is critical for timely intervention and treatment of premature ovarian failure. Anti-Müllerian hormone (AMH) and insulin-like growth factor binding protein 3 (IGF-BP3) have emerged as promising biomarkers for the diagnosis of the disease. In this study, we present a hydrogel-based immunosensor integrated with a radio frequency sensing platform for the rapid and ultrasensitive detection of AMH and IGF-BP3. Upon binding with free biomarkers, the hydrogel undergoes structural changes that modulate the capacitance between the resonators, enabling wireless detection via radio frequency signal transduction. The platform exhibits high sensitivity, broad dynamic detection ranges (10 -3 –10 5 pg/mL for AMH and 10–10 5 pg/mL for IGF-BP3, respectively), and ultralow limits of detection (0.7 fg/mL for AMH and 40.6 pg/mL for IGF-BP3, respectively). Quantitative testing of 56 clinical samples demonstrated the rapid and effective distinction between healthy individuals and patients, compared to the electrochemiluminescence immunoassay. Multivariate random forest prediction demonstrated biomarker levels are significantly correlated with clinical manifestations and ultrasound examination. The platform exhibits significant potential for broadening the assessment of biomarkers for premature ovarian failure, especially in home and community-based testing.
危险品化学品经营许可证(带存储)